Nyxoah Past Earnings Performance
Past criteria checks 0/6
Nyxoah's earnings have been declining at an average annual rate of -40.7%, while the Medical Equipment industry saw earnings growing at 5.2% annually. Revenues have been growing at an average rate of 70.3% per year.
Key information
-40.7%
Earnings growth rate
-23.6%
EPS growth rate
| Medical Equipment Industry Growth | 12.3% |
| Revenue growth rate | 70.3% |
| Return on equity | -44.1% |
| Net Margin | -993.8% |
| Next Earnings Update | 14 May 2024 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Nyxoah makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4 | -43 | 22 | 27 |
| 30 Sep 23 | 4 | -46 | 22 | 24 |
| 30 Jun 23 | 3 | -44 | 22 | 22 |
| 31 Mar 23 | 3 | -36 | 20 | 18 |
| 31 Dec 22 | 3 | -31 | 19 | 16 |
| 30 Sep 22 | 2 | -24 | 17 | 15 |
| 30 Jun 22 | 2 | -27 | 17 | 14 |
| 31 Mar 22 | 1 | -29 | 17 | 14 |
| 31 Dec 21 | 1 | -28 | 15 | 12 |
| 30 Sep 21 | 1 | -25 | 13 | 10 |
| 30 Jun 21 | 0 | -21 | 12 | 8 |
| 31 Mar 21 | 0 | -16 | 9 | 5 |
| 31 Dec 20 | 0 | -12 | 9 | 2 |
| 30 Sep 20 | 0 | -8 | 7 | 3 |
| 30 Jun 20 | 0 | -5 | 6 | 2 |
| 31 Mar 20 | 0 | -4 | 5 | 2 |
| 31 Dec 19 | 0 | -4 | 4 | 2 |
| 31 Dec 18 | 0 | -9 | 3 | 4 |
Quality Earnings: NYXH is currently unprofitable.
Growing Profit Margin: NYXH is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NYXH is unprofitable, and losses have increased over the past 5 years at a rate of 40.7% per year.
Accelerating Growth: Unable to compare NYXH's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: NYXH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (2.4%).
Return on Equity
High ROE: NYXH has a negative Return on Equity (-44.08%), as it is currently unprofitable.